Bristol-Myers Squibb Unusual Options Activity For August 21
Portfolio Pulse from Benzinga Insights
A significant investor has taken a bearish stance on Bristol-Myers Squibb (NYSE:BMY), with 53% of recent trades being bearish. The total amount for puts was $173,984 and for calls was $357,732. The targeted price range for the last 3 months has been $52.5 to $62.5. The current price of BMY is $62.02, down 0.07%. Analysts from Wells Fargo, Atlantic Equities, B of A Securities, Barclays, and BMO Capital have maintained their ratings on BMY, with price targets ranging from $62 to $85.
August 21, 2023 | 6:46 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Bristol-Myers Squibb has seen a bearish stance from a significant investor, with 53% of recent trades being bearish. The current price is $62.02, down 0.07%. Analysts have maintained their ratings, with price targets ranging from $62 to $85.
The bearish stance taken by a significant investor, along with the fact that 53% of recent trades have been bearish, could potentially drive the price down in the short term. However, the maintained ratings and price targets from analysts suggest a positive outlook in the longer term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100